China Isotope & Radiation Corp. Signs MoU With Brazil’s CNEN for Long‑Term Isotope Supply
China Isotope & Radiation Corporation (HKG: 1763) announced today that it has signed a Memorandum...
Deals
Wuhan Healthgen Announces STAR Market IPO of ORYZOGEN Shares
Wuhan Healthgen Biotechnology Corp. (SHA: 688765) today announced that the Shanghai Stock Exchange has approved...
Fosun Kairos Secures Series A Financing to Propel Cell‑Therapy Expansion
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA: 600196) announced that the Shenzhen Biopharmaceutical Industry Fund...
Novo Nordisk Secures Global Rights to Zaltenibart in Deal with Omeros
Novo Nordisk (NYSE: NVO) today announced the closing of a definitive asset purchase and license...
Boehringer Ingelheim & AimedBio Announce Global ADC Collaboration to Target Broad‑Spectrum Cancers
Boehringer Ingelheim today disclosed a worldwide collaboration and licensing agreement with AimedBio to develop a...
Pregene Partners with Kite to Pioneer Next-Generation In Vivo Therapies
Shenzhen Pregene Biopharma Co., Ltd. has entered into a License and Collaboration Agreement with Kite,...
Aosaikang’s AskGene Pharma Licenses ASKG712 to Visara for Macular Disease Treatment
Aosaikang Pharmaceutical Co., Ltd. (SHE: 002755) announced on October 17, 2025, that its subsidiary, AskGene...
Kexing Biopharm & Easton Biopharma Sign Exclusive Overseas Licensing Deal for Apalutamide
Kexing Biopharm (SHA: 688136) today announced a strategic cooperation agreement with Chengdu Easton Biopharmaceuticals Co.,...
I‑Mab Announces Global Transformation, NovaBridge Rebranding, and $37 M Acquisition of VIS‑101
I‑MAB Biopharma (NASDAQ: IMAB), a public company under the CBC Group, today revealed a strategic...
Viatris Acquires Aculys Pharma to Secure Japanese Rights for Pitolisant and Spydia
Viatris Inc. (NASDAQ: VTRS) today announced the completion of its acquisition of Aculys Pharma, gaining...
Gan & Lee Pharma, Fiocruz Sign MoU to Advance GZR4 and GZR102 Insulin Candidates
Gan & Lee Pharmaceuticals (SHA: 603087) announced today that it has signed a Memorandum of...
Hansoh Pharma Grants Roche Exclusive Global Rights to CDH17‑Targeting ADC HS‑20110
Hansoh Pharmaceutical Group (HKG: 3692) today announced a licensing agreement with Roche (SWX: ROG, OTCMKTS:...
Leads Biolabs, Dianthus Therapeutics Announce Global Partnership for LBL‑047 Bispecific Fusion Protein
Nanjing Leads Biolabs Co., Ltd. (HKG: 9887) today announced an exclusive global partnership with Dianthus Therapeutics...
NeuroGen Pharma Secures Exclusive Rights to Brexpiprazole Orally Disintegrating Film from Bocimed
China‑based NeuroGen Pharma and Bocimed announced today that they have entered into an exclusive product‑transfer...
Jacobio Pharmaceuticals Secures 80% Equity Investment in Jacoray from Oceanpine Capital
Jacobio Pharmaceuticals (HKG: 1167) today announced a capital‑increase and equity‑transfer agreement that will see Shanxi...
Haihe Biopharma Grants Taiho Pharmaceutical Exclusive License for Risovalisib in Japan
China‑based Haihe Biopharma Co., Ltd. (the “Licensor”) announced today that it has entered into an...
Genesis Healthcare & MGI Sign Strategic MOU to Accelerate Precision Medicine in Japan
Genesis Healthcare, a leading Japanese genetic‑testing provider, today announced the signing of a Memorandum of...
Nuance Pharma Partners with Stallergenes Greer to Launch Actair in China
Nuance Pharma, an innovation-focused biopharmaceutical company, and Stallergenes Greer, a global leader in the allergy...
Uni-Bio Science Partners with Sinovac to Expand Teriparatide Injection Globally
Uni-Bio Science Group Limited (HKG: 0690), a China-based company, announced on September 12, 2025, that...
Adagene Expands Exelixis Collaboration to Include Third Target Using SAFEbody Technology
Adagene Inc. (NASDAQ: ADAG) announced on September 16, 2025, that its collaboration and license agreement...